TrialMedical molecular morphology2019

Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.

Takahiko Sakaue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.